Conference Code: 20US10ICDDAE
Conference Aims and Objectives
The ICDDAE 2020: 22nd International Conference on Drug Designing and Adverse Effects
aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Drug Designing and Adverse Effects. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Drug Designing and Adverse Effects.
Call for Contributions
All honorable authors are kindly encouraged to contribute to and help shape the conference through submissions of their research abstracts, papers and e-posters. Also, high quality research contributions describing original and unpublished results of conceptual, constructive, empirical, experimental, or theoretical work in all areas of Drug Designing and Adverse Effects are cordially invited for presentation at the conference. The conference solicits contributions of abstracts, papers and e-posters that address themes and topics of the conference, including figures, tables and references of novel research materials.WASET
Federated conference series is an event that brings together significant number of recurring events; academic conferences, symposia, workshops, special sessions, and plenary talks in the field of science and technology since inception in 1999. Each event may run over any span of time within the conference days.
All submitted conference papers will be blind peer reviewed by three competent reviewers. The peer-reviewed conference proceedings are indexed in the International Science Index (ISI)
, Google Scholar
, Semantic Scholar
, and other index databases. The conference abstracts and proceedings book, CD and certificate of presentation will be distributed to participants at the conference registration desk. Impact Factor Indicators
Special Journal Issues
has teamed up with the Special Journal Issue on Drug Designing and Adverse Effects
A number of selected high-impact full text papers will also be considered for the special journal issues. All submitted papers will have the opportunity to be considered for this Special Journal Issue. The paper selection will be carried out during the peer review process as well as at the conference presentation stage. Submitted papers must not be under consideration by any other journal or publication. The final decision for paper selection will be made based on peer review reports by the Guest Editors and the Editor-in-Chief jointly. Selected full-text papers will be published online free of charge.
Conference Sponsor and Exhibitor Opportunities
The Conference offers the opportunity to become a conference sponsor or exhibitor. To participate as a sponsor or exhibitor, please download and complete the Conference Sponsorship Request Form
|Abstracts/Full-Text Paper Submission Deadline
||December 10, 2019
|Notification of Acceptance/Rejection
||February 20, 2020
|Final Paper (Camera Ready) Submission & Early Bird Registration Deadline
||September 10, 2020
||October 10 - 11, 2020
Please ensure your submission meets the conference's strict guidelines for accepting scholarly papers. Downloadable versions of the check list for
Please refer to the Paper Submission GUIDE
before submitting your paper.
Selected Conference Papers
1) 21st Century Biotechnological Research and Development Advancements for Industrial Development in IndiaMonisha Isaac 2) Patient Support Program in Pharmacovigilance: Foster Patient Confidence and ComplianceAtul Khurana, Rajul Rastogi, Hans-Joachim Gamperl 3) Management Software for the Elaboration of an Electronic File in the Pharmaceutical Industry Following Mexican RegulationsM. Peña Aguilar Juan, Ríos Hernández Ezequiel, R. Valencia Luis 4) Intellectual Property Rights and Health Rights: A Feasible Reform Proposal to Facilitate Access to Drugs in Developing CountriesM. G. Cattaneo 5) Preparation of Polymer-Stabilized Magnetic Iron Oxide as Selective Drug Nanocarriers to Human Acute Myeloid LeukemiaKheireddine El-Boubbou 6) Formulation of Extended-Release Gliclazide Tablet Using a Mathematical Model for Estimation of HypromelloseFarzad Khajavi, Farzaneh Jalilfar, Faranak Jafari, Leila Shokrani 7) Honey Contamination in the Republic of KazakhstanB. Sadepovich Maikanov, Z. Shabanbayevich Adilbekov, R. Husainovna Mustafina, L. Tyulegenovna Auteleyeva 8) Risk of Occupational Exposure to Cytotoxic Drugs: The Role of Handling Procedures of Hospital WorkersJ. Silva, P. Arezes, R. Schierl, N. Costa 9) Polydopamine Nanoparticle as a Stable and Capacious Nano-Reservoir of RifampicinTasnuva Tamanna, Aimin Yu 10) Determinants of Profitability in Indian Pharmaceutical Firms in the New Intellectual Property Rights RegimeShilpi Tyagi, D. K. Nauriyal 11) Use of Curcumin in Radiochemotherapy Induced Oral Mucositis Patients: A Control Trial Study Shivayogi Charantimath 12) Quality Based Approach for Efficient Biologics ManufacturingTakashi Kaminagayoshi, Shigeyuki Haruyama 13) Controlled Release of Glucosamine from Pluronic-Based Hydrogels for the Treatment of OsteoarthritisPapon Thamvasupong, Kwanchanok Viravaidya-Pasuwat 14) The Effect of a Three-Month Training Program on the Back Kyphosis of Former Male AddictsM. J. Pourvaghar, Sh. Khoshemehry 15) Learners’ Violent Behaviour and Drug Abuse as Major Causes of Tobephobia in SchoolsPrakash Singh
Similar conferences about Pharmacological and Pharmaceutical Sciences